Free microbiology thesis topics and microbiology dissertation topics across three open sections in the tiles below — basic and general microbiology (general bacteriology, bacterial structure, pathogenesis, bacterial genetics, bacterial identification and antimicrobial susceptibility testing), applied and clinical microbiology (clinical bacteriology, gram-positive cocci, gram-negative bacilli, gram-negative cocci, anaerobic, spore-forming and fastidious bacteria) and novel and technology-based microbiology (artificial intelligence in diagnostics, rapid molecular and point-of-care testing, genomics and metagenomics, advanced antimicrobial resistance, and laboratory automation). Nothing is locked.
Whether you need MD microbiology thesis topics, DNB microbiology thesis topics, bacteriology, virology, mycology or parasitology research topics for postgraduates, or a ready microbiology thesis protocol, every title is written so it can be converted into a full synopsis with a defined study design, sample size and measurable outcome. Open any section and use the search box in its top right corner to jump to a specific area: type MRSA, ESBL, carbapenem, biofilm or blood culture instead of scrolling.
The lists suit MD (Microbiology) and DNB Microbiology residents under MUHS, RGUHS, NTR UHS, MGR Medical University, KNRUHS and other Indian health universities, and equally Saudi Board, Arab Board, DHA, DOH, MOHAP, QCHP, HMC, OMSB, KIMS and NHRA trainees in medical microbiology and laboratory medicine across the GCC who need a research proposal rather than a thesis synopsis.
Microbiology has the steadiest workflow of any postgraduate speciality: samples arrive in your laboratory every day whether you recruit anyone or not. A prospective study on consecutive clinical isolates needs no patient contact beyond routine care, and a retrospective study on your laboratory information system needs none at all. That makes antimicrobial resistance surveillance, isolate profiling, sample-type-specific pathogen spectra and diagnostic method comparisons the most reliably completed microbiology theses.
What derails protocols is reagent and platform dependence. A topic built on PCR, multiplex panels, MALDI-TOF, whole genome sequencing or automated blood culture systems will stall if the machine is not in routine use, the consumables are unfunded, or the service contract lapses mid-study. Before you finalise a title, confirm which platforms your laboratory actually runs day to day, which media and antibiotic discs are reliably stocked, and who is paying for anything extra. Phenotypic methods — double disc synergy, combined disc, modified carbapenem inactivation, E-test, tube dilution — remain fully acceptable for a thesis and cost a fraction of molecular work.
Once the title is fixed, the next step is the microbiology thesis protocol — the synopsis in India, the research proposal in the Gulf. Both need the same core: background and rationale, review of literature, aims and objectives, study design, setting and duration, inclusion and exclusion criteria, a sample size calculation derived from a cited study, the identification and susceptibility methods you will use, a statistical analysis plan, ethical considerations and consent, and Vancouver-style references. Microbiology protocols must also name the guideline edition governing your susceptibility testing and interpretation — CLSI M100 by year, or EUCAST by version — along with the quality control strains you will run, because breakpoints are revised annually and a reviewer will ask.
Residents outside India face a different document. Instead of a university thesis synopsis, most GCC training programmes require a research proposal approved by an institutional review board before data collection begins — an SCFHS research proposal in Saudi Arabia, a QCHP or HMC proposal in Qatar, a DHA, DOH or MOHAP-aligned proposal in the UAE, an OMSB proposal in Oman, a KIMS proposal in Kuwait, or an NHRA-aligned proposal in Bahrain. The clinical questions are identical to the ones listed in the sections above; what changes is the structure, with far more weight on feasibility, budget, timeline and data management, and far less on the historical review of literature.
Two things matter more in a Gulf microbiology proposal than in an Indian one. Biosafety and specimen governance are examined in detail — biosafety level for the organisms handled, isolate storage and retention, whether any material or sequence data leaves the institution, and the basis for waiver of consent on residual clinical samples. And the pathogen mix tilts the shortlist: brucellosis, MERS-CoV and other respiratory viruses, carbapenem-resistant Acinetobacter and Klebsiella in intensive care, and healthcare-associated infection surveillance in JCI-accredited hospitals carry stronger local numbers in the Gulf, while tuberculosis, enteric fever, dengue and community-acquired resistance carry the volume in Indian departments.
Training outside India? Choose the path that matches your programme.
Board and residency trainees — Saudi Board, Arab Board, DHA, DOH, MOHAP, QCHP, HMC, OMSB, KIMS, NHRA:
Get a microbiology research proposal for your board programme →
PhD and Master's candidates — university-registered research in medical microbiology, infectious diseases, molecular diagnostics or public health:
Submit your PhD or Master's research topic →
The most dependable microbiology thesis topics in India are antimicrobial resistance surveillance studies in a defined sample type or clinical unit; phenotypic detection studies for ESBL, AmpC, carbapenemase or methicillin resistance; bacteriological profile and susceptibility pattern studies in urinary tract infection, bloodstream infection, surgical site infection, ventilator-associated pneumonia or neonatal sepsis; biofilm production and its correlation with resistance; and diagnostic method comparisons against a reference standard. All of these run on isolates arriving in your laboratory as part of routine care.
Yes. Every section is open — the full topic lists are free to read, copy and discuss with your guide, with no subscription and no login required to see the topics.
Use whichever your laboratory already follows for routine reporting, and say so explicitly in the protocol with the edition and year — CLSI M100 is the norm in most Indian laboratories, while EUCAST is widely used across the Gulf and Europe. Do not mix the two within a single study. Breakpoints are revised annually, so state the exact version you applied, name the quality control strains you will run alongside, and keep that version fixed for the whole data-collection period even if a new edition is released midway.
Decide before you write the protocol and state it plainly. Counting repeat isolates from the same patient as independent observations inflates your resistance rates and is a standard reviewer objection. The usual convention is one isolate per patient per species per study period — the first significant isolate — with duplicates excluded by a stated rule. If you keep repeats deliberately, for example to study resistance emerging during therapy, say so and account for the correlation in your analysis.
Resistance prevalence studies size on the expected proportion of resistant isolates from a cited local study, your chosen alpha (usually 0.05) and an absolute precision you set, typically five per cent. Diagnostic accuracy studies size on expected sensitivity or specificity and the anticipated prevalence of the target organism. Most single-centre microbiology studies land between 150 and 400 isolates, though this varies sharply by sample type — blood cultures yield far fewer positives than urine. Check your laboratory's annual positivity numbers before you commit to a figure.
Choose a phenotypic design. Double disc synergy and combined disc tests for ESBL, the modified carbapenem inactivation method and EDTA-modified variants for carbapenemases, cefoxitin disc diffusion for methicillin resistance, D-test for inducible clindamycin resistance, tube adherence and microtitre plate assays for biofilm, and E-test or broth microdilution for minimum inhibitory concentrations all produce solid, publishable theses without a thermocycler. If molecular confirmation is central to the question, restrict it to a subset of isolates and state the funding source explicitly in the protocol.
Yes. The clinical questions are the same; only the document format differs. Saudi Board residents in medical microbiology and laboratory medicine need an SCFHS-style research proposal for IRB submission, which is shorter than an Indian thesis synopsis and places more emphasis on feasibility, budget, timeline, data management, biosafety and specimen governance. Use the international link above to request that format.
Yes. Arab Board trainees, residents licensed under DHA, DOH and MOHAP in the UAE, QCHP and HMC residents in Qatar, OMSB residents in Oman, KIMS residents in Kuwait and NHRA-licensed trainees in Bahrain can all use these titles. What changes is the ethics and biosafety pathway, the isolate custody documentation expected, and the local pathogen mix — not the research question itself.
Yes to approval, usually not to individual consent. Indian universities and the NBEMS require institutional ethics committee clearance before data collection begins, and every GCC training programme requires IRB or REC approval. Studies on residual clinical specimens and isolates already sent for routine diagnostic testing are typically granted a waiver of consent, on the basis that no additional sample is taken, the data are anonymised and patients are not contacted. Any study needing an extra swab, an extra blood draw or patient interview does require individual written consent. Data collected before the approval date is generally not accepted in the final thesis.